Home About us Pipeline News & Events Contact

Charcot-Marie-Tooth Association with Affectis

The Charcot-Marie-Tooth Association Enters Collaboration with Affectis to Advance Therapies for Charcot-Marie-Tooth 1A Disorder

20 April 2015

Dortmund, Germany, 20 April, 2015 – The Charcot-Marie-Tooth Association (CMTA) announced today that is has entered into a collaboration with Affectis Pharmaceuticals AG. The goal of the collaboration will be to evaluate the pharmacology of small molecule antagonists of the P2X7 ligand-gated ion channel that are being jointly developed by Affectis and the LDC. The CMTA consortium will evaluate the efficacy of advanced Affectis compounds in neurological and behavioral models of CMT1A...

Download File (204KB):
CMTA-Affectis Collaboration Announcement